4//SEC Filing
HOLLER FRANK A 4
Accession 0001209191-21-036798
CIK 0001582313other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:07 PM ET
Size
19.6 KB
Accession
0001209191-21-036798
Insider Transaction Report
Form 4
HOLLER FRANK A
Director
Transactions
- Sale
Common Shares
2021-05-27$18.69/sh−2,579$48,202→ 152,138 total - Exercise/Conversion
Common Shares
2021-05-27$3.76/sh+36,008$135,390→ 160,628 total - Tax Payment
Common Shares
2021-05-27$18.88/sh−507$9,572→ 124,620 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-27−3,086→ 0 totalExercise: $3.76Exp: 2021-05-28→ Common Shares (3,086 underlying) - Exercise/Conversion
Common Shares
2021-05-27$3.76/sh+3,086$11,603→ 125,127 total - Sale
Common Shares
2021-05-27$18.68/sh−8,485$158,500→ 143,653 total - Tax Payment
Common Shares
2021-05-27$18.88/sh−5,911$111,600→ 154,717 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-27−36,008→ 0 totalExercise: $3.76Exp: 2021-05-28→ Common Shares (36,008 underlying)
Holdings
- 1,184(indirect: By Spouse)
Common Shares
Footnotes (6)
- [F1]The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
- [F2]Represents the closing price of the Company's common shares on May 26, 2021, which was converted to a Canadian dollar amount for purposes of net settlement calculations.
- [F3]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein
- [F4]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $18.54 to $18.92, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein
- [F5]The shares subject to the option fully vested on December 31, 2013. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.
- [F6]Expiration date differs from originally reported date due to an automatic extension provided by the option plan as a result of the original expiration date falling during a Company blackout period and a lock-up agreement period.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0000938801
Filing Metadata
- Form type
- 4
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 4:07 PM ET
- Size
- 19.6 KB